Winfield Associates’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
VAM
MNG
Winfield Associates's ABEV Position: Q1 2018 in Review
Winfield Associates sold out of Ambev (ABEV) in Q1 2018, closing a stake of 2,970 shares — an estimated $20K sold.
Winfield Associates first reported a position in ABEV in Q1 2016 and held it in 8 quarters. The position peaked at $20K in Q4 2017. 334 funds tracked by Wall St. Rank hold ABEV as of Q1 2018.
- Winfield Associates reported no remaining Ambev position as of Q1 2018 after selling out during the quarter.
- Winfield Associates sold 2,970 Ambev shares in Q1 2018, an estimated $20K.
- Winfield Associates first reported a position in Ambev in Q1 2016 and held it in 8 quarters.
- Winfield Associates's Ambev position peaked at $20K in Q4 2017.
- 334 funds tracked by Wall St. Rank held Ambev as of Q1 2018.
Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.